openPR Logo
Press release

Epigenetics Drugs & Diagnostic Technologies Market Seeking Excellent Growth

07-24-2021 12:43 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Epigenetics Drugs & Diagnostic Technologies Market

Epigenetics Drugs & Diagnostic Technologies Market

Epigenetics can be defined as the study of chemical modifications of some specific genes of an organism. A gene can be altered with change in the sequence of its DNA or epigenetic programming. Epigenetic drugs make it possible to reverse the aberrant gene expression which leads to various disease states.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/4026

The global epigenetic drugs and diagnostic technologies market was valued at US$ 6,800.3 Mn in 2019 and is forecast to reach a value of US$ 28,606.6 Mn by 2027 at a CAGR of 19.7% between 2020 and 2027.

Increasing prevalence of cancer is expected to propel growth of the global epigenetic drugs and diagnostic technologies market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Epigenetic is the study of chemical modifications of some specific genes of an organism. Epigenetic drugs are used to reverse the abnormal gene expression which leads to different types of disease such as cancer, heart disease, diabetes, and mental illnesses. Increasing prevalence of cancer, increasing research and development for new drug molecule along with increasing investment in biotechnology industry is expected to propel the market growth during the forecasted period.

Major players in the market are also focused on adopting collaboration strategies to expand their product portfolio. For instance, in June 2020, Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics for R&D of new therapies, collaborated with Institute of Medical and Molecular Genetics (INGEMM) of the La Paz University Hospital in Madrid for R&D of precision medicine in patients with Phelan-McDermid Syndrome.

Buy Now with Discount for Premium Report : https://www.coherentmarketinsights.com/promo/buynow/4026

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epigenetics Drugs & Diagnostic Technologies Market Seeking Excellent Growth here

News-ID: 2336328 • Views:

More Releases from Coherent Market Insights

Radiation Oncology Market Set to Witness Significant Growth by 2025-2032 | Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems
Radiation Oncology Market Set to Witness Significant Growth by 2025-2032 | Varia …
The global radiation oncology market is estimated to be valued at USD 12.51 Bn in 2025 and is expected to reach USD 16.31 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Radiation Oncology Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth
Medical Oxygen Cylinder Market Share, Revenue, Price, Growth Rate, and Ranking Analysis Report 2025-2032 | Luxfer Gas Cylinders, Catalina Cylinders, Worthington Industries
Medical Oxygen Cylinder Market Share, Revenue, Price, Growth Rate, and Ranking A …
The global medical oxygen cylinder market is estimated to be valued at USD 4.74 Bn in 2025 and is expected to reach USD 6.90 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Medical Oxygen Cylinder Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,
Organic Skincare Market to reach Blatant Growth in Coming years by 2032 |Shiseido Company Limited, Natura & Co., The Estee Lauder Companies, Yves Rocher
Organic Skincare Market to reach Blatant Growth in Coming years by 2032 |Shiseid …
The global organic skincare market is estimated to be valued at USD 13.56 Bn in 2025 and is expected to reach USD 24.47 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Organic Skincare Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth
Frozen Dessert Market to Witness Massive Growth by 2032 |Nestlé, Unilever, General Mills Inc., Dippin' Dots LLC
Frozen Dessert Market to Witness Massive Growth by 2032 |Nestlé, Unilever, Gen …
The Global Frozen Dessert Market is estimated to be valued at USD 128.56 Bn in 2025 and is expected to reach USD 172.62 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Frozen Dessert Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth

All 5 Releases


More Releases for Epigenetic

Nucleic Acid Therapeutics Market Trends Emphasizing Epigenetic and microRNA Modu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nucleic Acid Therapeutics Market - (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Epigenetics Market - Harnessing the Epigenetic Revolution: Transforming the Futu …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Epigenetics Market. Epigenetics Market: https://www.growthplusreports.com/report/epigenetics-market/9171 The Epigenetics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy. The Epigenetics market
Epigenetic Market 2021 | Detailed Report
The Epigenetic research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the Epigenetic industry to
Epigenetic Market Forecast By End-use Industry 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,
Epigenetic Market to Observe Strong Development by 2016-2026
The epigenetic process includes phosphorylation, methylation, sumolyation, acetylation and ubiquitylation etc. of DNA as well as histones resulting in changes in Phenotypes. These changes are modified with environmental conditions. Epigenetic market is now an emerging field. There are various diagnostic tests available now that detect epigenetic changes. There are some FDA approved epigenetic drugs. Other than many diagnostic companies, many biopharmaceutical and pharmaceutical companies are also very active in the
Epigenetic Market Plying for Significant Growth During 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,